Accel Wealth Management Purchases New Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Accel Wealth Management bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 415 shares of the healthcare conglomerate’s stock, valued at approximately $219,000.

Several other institutional investors have also recently bought and sold shares of UNH. Trueblood Wealth Management LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $2,751,000. Successful Portfolios LLC boosted its holdings in UnitedHealth Group by 5.8% in the fourth quarter. Successful Portfolios LLC now owns 1,214 shares of the healthcare conglomerate’s stock valued at $639,000 after acquiring an additional 67 shares during the last quarter. Great Lakes Retirement Inc. boosted its holdings in UnitedHealth Group by 4.5% in the fourth quarter. Great Lakes Retirement Inc. now owns 11,925 shares of the healthcare conglomerate’s stock valued at $6,278,000 after acquiring an additional 509 shares during the last quarter. Hill Island Financial LLC bought a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $227,000. Finally, WASHINGTON TRUST Co boosted its holdings in shares of UnitedHealth Group by 23.1% during the 4th quarter. WASHINGTON TRUST Co now owns 1,465 shares of the healthcare conglomerate’s stock worth $771,000 after buying an additional 275 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.3 %

Shares of UnitedHealth Group stock traded up $1.60 during midday trading on Thursday, reaching $494.70. 3,805,551 shares of the company’s stock traded hands, compared to its average volume of 4,097,774. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. The company has a market cap of $456.08 billion, a PE ratio of 20.70, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54. The stock has a 50 day moving average of $503.10 and a 200-day moving average of $518.61. UnitedHealth Group Incorporated has a 12 month low of $445.68 and a 12 month high of $554.70.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. The company had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm’s revenue for the quarter was up 14.1% on a year-over-year basis. During the same quarter in the prior year, the company earned $5.34 earnings per share. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 27.82 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.52%. UnitedHealth Group’s payout ratio is 31.54%.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the topic of a number of research analyst reports. HSBC restated a “reduce” rating and set a $480.00 price target (down from $550.00) on shares of UnitedHealth Group in a report on Monday, December 18th. Truist Financial reaffirmed a “buy” rating and set a $610.00 target price on shares of UnitedHealth Group in a research report on Thursday, November 30th. Royal Bank of Canada reissued an “outperform” rating and issued a $596.00 price target on shares of UnitedHealth Group in a research report on Thursday, February 29th. Erste Group Bank reaffirmed a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Finally, Oppenheimer reaffirmed an “outperform” rating and set a $610.00 target price on shares of UnitedHealth Group in a research report on Wednesday, January 17th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $579.33.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.